Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM27D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,345
Award facts
- Contract value 100% obligated
- $28,344.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,344.87 to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials. This contract, issued on December 16, 2025, with an ultimate completion date of December 17, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively bid and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio supplying medications and medical supplies to military and veteran healthcare systems. Renflexis is a biosimilar to Remicade used to treat various inflammatory conditions, and this procurement reflects the Defense Logistics Agency's ongoing efforts to source critical pharmaceutical products for the Defense Health Agency and broader military healthcare infrastructure. The delivery order's compressed timeline—issued and due for completion within one day—indicates an urgent replenishment requirement within DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FM27D?
SPE2DR26FM27D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FM27D worth?
The government has obligated $28,345 on SPE2DR26FM27D.
Is contract SPE2DR26FM27D an order under another contract?
Yes. SPE2DR26FM27D is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM27D competed?
The extent of competition for SPE2DR26FM27D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award